$ SIE came up on a scan & almost looks attractive (liquidity is the main issue). Weekly chart: looks to be making a higher low - looks worth taking a position and topping up if it goes to around 2 Cents
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%